Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953402 · ClinicalTrials.gov registry record
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
A clinical trial, sponsored by Bristol-Myers Squibb.
- Recruiting
- Registry status
- 1,182
- Enrollment target
NCT05953402 is a clinical trial that is actively recruiting participants, run by Bristol-Myers Squibb. The registered enrollment target is 1,182 participants.
The verdict
NCT05953402 is actively recruiting participants, sponsored by Bristol-Myers Squibb.
- RECRUITING
- Registry status
- 1,182 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,182 participants |
| Start Date | 2026-04-21 |
| Est. Completion | 2034-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05953402
The ClinicalTrials.gov registry entry for NCT05953402 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05953402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05953402 about?
NCT05953402 is a clinical study titled "A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring". The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
What is the current status of trial NCT05953402?
This trial is currently recruiting. The enrollment target is 1,182 participants. The study started on 2026-04-21. Estimated completion is 2034-06-30.
Who is sponsoring clinical trial NCT05953402?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.